NCT01146535 - Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Influenza A Virus Infection

Interventions

DRUG

Interferon-alpha

150 IU lozenges bid for 5 days

DRUG

Oseltamivir

75 mg capsules bid for 5 days

OTHER

maltose

200 mg maltose lozenges bid for 5 days

Trial Locations (4)

Chang Gung Medical Foundation, LinKou Branch, Guishan

Taiwan Municipal Hospital, Tainan City

Show-Chwan Memorial Hospital, Changhua

Kaohsiung Veterans General Hospital, Kaohsiung City